We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
In a study of more than 4,000 UK volunteers, antibody levels were around 40 percent higher in people who had the Valneva vaccine than in those who had the Oxford/AstraZeneca jab, while Valneva’s also had fewer side-effects.
The Government scrapped the deal for doses last month. Valneva claims it was over an alleged breach of the agreement which it has “strenuously” denied.
The firm still plans to manufacture the vaccine in West Lothian and hopes to see it approved for use in Britain before next year.
Source: Read Full Article
